VF
AGIO icon

Virtu Financial’s Agios Pharmaceuticals AGIO Stock Holding History

Virtu Financial’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-21,392
Closed -$724K – 1546
2026
Q1 		$724K Buy
+21,392
New +$607K 0.03% 437
2024
Q3 		– Sell
-4,960
Closed -$214K – 1320
2024
Q2 		$214K Buy
+4,960
New +$179K 0.01% 679
2021
Q3 		– Sell
-4,148
Closed -$229K – 1449
2021
Q2 		$229K Buy
+4,148
New +$232K 0.02% 897
2019
Q2 		– Sell
-5,218
Closed -$352K – 1422
2019
Q1 		$352K Buy
+5,218
New +$304K 0.02% 713
2018
Q3 		– Sell
-6,588
Closed -$555K – 1489
2018
Q2 		$555K Buy
+6,588
New +$575K 0.03% 738
2015
Q3 		– Sell
-3,123
Closed -$347K – 309
2015
Q2 		$347K Buy
+3,123
New +$336K 0.03% 245

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Virtu Financial's AGIO Position: Q2 2026 in Review

Virtu Financial sold out of Agios Pharmaceuticals (AGIO) in Q2 2026, closing a stake of 21,392 shares — an estimated $724K sold.

Virtu Financial first reported a position in AGIO in Q2 2015 and held it in 6 quarters. The position peaked at $724K in Q1 2026. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Virtu Financial reported no remaining Agios Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Virtu Financial sold 21,392 Agios Pharmaceuticals shares in Q2 2026, an estimated $724K.
  • Virtu Financial first reported a position in Agios Pharmaceuticals in Q2 2015 and held it in 6 quarters.
  • Virtu Financial's Agios Pharmaceuticals position peaked at $724K in Q1 2026.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.